Xyrem
Ended Awarded Last action
- Contract number
- 36C26124N0556
- Awardee
-
Jazz Pharmaceuticals, Inc. UEI H9AXCNRA5NE6
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $28,947
Award facts
- Contract value 100% obligated
- $28,946.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Palo Alto, CA 94304, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$17,400 | |
| Original award | $46,347 |
About this award
Jazz Pharmaceuticals, Inc. was awarded a $28,946.95 firm fixed price delivery order for XYREM (sodium oxybate) by the Department of Veterans Affairs' Veterans Integrated Service Network 21 on April 1, 2024, with completion targeted for July 1, 2024. The award was issued without a set-aside designation, reflecting unrestricted competition. Performance will occur in Palo Alto, California, where Jazz Pharmaceuticals maintains its headquarters. This delivery order is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and represents one of numerous orders the VA has placed with Jazz Pharmaceuticals for specialty medications supporting veteran healthcare services.
XYREM is a medication indicated for treating narcolepsy and sleep disorders in the veteran population, and Jazz Pharmaceuticals serves as the VA's primary supplier for this specialty pharmaceutical through a single-award Blanket Purchase Agreement valued at $161.2 billion, expiring August 15, 2026. The BPA authorizes procurement of both XYREM and Xywav across multiple Veterans Integrated Service Networks nationwide. Jazz Pharmaceuticals, a for-profit biopharmaceutical manufacturer headquartered in Palo Alto and specializing in neurological and sleep disorder treatments, has demonstrated sustained federal contracting activity since 2021, with no subcontracting arrangements noted on identified awards, positioning the company as a critical supplier in the VA's specialized healthcare delivery network.
Quick answers
Who was awarded contract 36C26124N0556?
36C26124N0556 was awarded to Jazz Pharmaceuticals, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on April 1, 2024.
How much is contract 36C26124N0556 worth?
The government has obligated $28,947 on 36C26124N0556.
Is contract 36C26124N0556 an order under another contract?
Yes. 36C26124N0556 is a delivery order under 36F79719D0205, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0556 competed?
The extent of competition for 36C26124N0556 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award